Home
/
BIODESIX INC
/
Financials
/
Quarterly
BIODESIX INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIODESIX INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.77M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$20.02M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$17.96M
May 13, 2025
Q3
2025
Sep 30, 2024
$18.15M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$17.93M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$14.82M
May 13, 2025
Q3
2024
Sep 30, 2023
$13.49M
Nov 1, 2024
Q2
2024
Jun 30, 2023
$11.87M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$9.06M
May 8, 2024
Q3
2023
Sep 30, 2022
$11.11M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$10.95M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$6.55M
May 11, 2023
Q3
2022
Sep 30, 2021
$6.53M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$11.89M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$28.87M
May 11, 2022
Q3
2021
Sep 30, 2020
$9.19M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$4.24M
Aug 10, 2021
Q1
2021
Mar 31, 2020
$5.10M
May 11, 2021
Q3
2020
Sep 30, 2019
$3.94M
Dec 10, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.72M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($11.47M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($11.47M)
Nov 3, 2025
Q2
2025
Mar 31, 2025
($11.10M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($11.10M)
May 13, 2025
Q3
2025
Mar 31, 2025
($11.10M)
Nov 3, 2025
Q3
2025
Sep 30, 2024
($10.26M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($10.81M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($10.81M)
Nov 3, 2025
Q2
2025
Mar 31, 2024
($13.61M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($13.61M)
Nov 3, 2025
Q1
2025
Mar 31, 2024
($13.61M)
May 13, 2025
Q3
2024
Sep 30, 2023
($10.95M)
Nov 1, 2024
Q3
2024
Jun 30, 2023
($13.36M)
Nov 1, 2024
Q2
2024
Jun 30, 2023
($13.36M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($18.70M)
May 8, 2024
Q3
2024
Mar 31, 2023
($18.70M)
Nov 1, 2024
Q2
2024
Mar 31, 2023
($18.70M)
Aug 7, 2024
Q3
2023
Sep 30, 2022
($13.70M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($15.82M)
Aug 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.05M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($9.72M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($9.14M)
May 13, 2025
Q3
2025
Sep 30, 2024
($8.59M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($8.24M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($11.02M)
May 13, 2025
Q3
2024
Sep 30, 2023
($7.17M)
Nov 1, 2024
Q2
2024
Jun 30, 2023
($10.93M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($16.37M)
May 8, 2024
Q3
2023
Sep 30, 2022
($10.61M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($11.63M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($14.46M)
May 11, 2023
Q3
2022
Sep 30, 2021
($13.09M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($10.59M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($5.58M)
May 11, 2022
Q3
2021
Sep 30, 2020
($6.24M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($5.62M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($8.42M)
May 11, 2021
Q3
2020
Sep 30, 2019
($9.03M)
Dec 10, 2020